Alliance Pharma (LSE:APH) Change In Receivables : £4.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Change In Receivables?

Alliance Pharma's change in receivables for the quarter that ended in Jun. 2023 was £8.3 Mil. It means Alliance Pharma's Accounts Receivable declined by £8.3 Mil from Dec. 2022 to Jun. 2023 .

Alliance Pharma's change in receivables for the fiscal year that ended in Dec. 2022 was £-18.7 Mil. It means Alliance Pharma's Accounts Receivable increased by £18.7 Mil from Dec. 2021 to Dec. 2022 .

Alliance Pharma's Accounts Receivable for the quarter that ended in Jun. 2023 was £36.3 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Alliance Pharma's Days Sales Outstanding for the six months ended in Jun. 2023 was 81.30.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Alliance Pharma's liquidation value for the six months ended in Jun. 2023 was £-169.9 Mil.

Alliance Pharma Change In Receivables Historical Data

The historical data trend for Alliance Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Change In Receivables Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-7.63

-0.50

6.73

-6.15

-18.72

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial															-8.88	2.73	-14.42	-4.31	8.33

Alliance Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £4.0 Mil.

Alliance Pharma (LSE:APH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Alliance Pharma's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	36.259	/	81.398	*	91
=	81.30

2. In Ben Graham's calculation of liquidation value, Alliance Pharma's accounts receivable are only considered to be worth 75% of book value:

Alliance Pharma's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	26.112	-	236.761	+	0.75 * 36.259	+	0.5 * 27.096
=	-169.9

Alliance Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).